Axtria Insights



AxtriaTM Inc. announces a strategic agreement to improve productivity & effectiveness through incentives and bonuses for all global commercial teams on the cloud-based Axtria SalesIQTM platform.

Berkeley Heights, New Jersey – November 29, 2016

Axtria, a global big data analytics company, is pleased to announce a strategic agreement with Boehringer Ingelheim (a top 20 pharmaceutical manufacturer) to provide end-to-end Incentive Compensation services to its global commercial teams. As part of the agreement, over 12,000 users across Boehringer Ingelheim’s global markets will be deployed on Axtria’s SalesIQ. There are already 3,500 users in the US and Japan live on the platform today.

Previously, all bonus and incentive processes at Boehringer Ingelheim were localized within each business unit and region. With a focus on driving field force effectiveness, Boehringer Ingelheim aims to standardize on a modern, enterprise-grade platform that aligns compensation strategies and implements best practices globally.

“Axtria proved that they not only have a strong platform and experience to deploy in an agile way a state of the art bonuses and incentives platform but also proved they have a strong global experience on how to bring to the next level Customer Facing Roles motivation through bonuses and incentives therefore impacting their productivity and effectiveness.” said Dave Arnold, Head of Customer Engagement Excellence at Boehringer Ingelheim.

Axtria SalesIQ is an integrated, cloud based sales planning and operations platform covering Territory Alignment, Call Planning, Incentive Compensation and Field Reporting. It is built on the platform and integrates natively with Veeva CRM.

As part of the transformation, Boehringer Ingelheim expects Axtria SalesIQ to deliver:

  • A scalable, enterprise-grade incentive compensation platform
  • A global solution that drives standardization across markets
  • Flexibility to work with localized data, currencies, credits and languages
  • Agility to adapt and grow with evolving business needs
  • A reduction in administration errors, often caused by spreadsheets and manual processes
  • Improvements in controls and transparency across business processes

“We are excited to be partnering with Boehringer Ingelheim on this strategic initiative” said Jassi Chadha, Founder and CEO of Axtria. “This is a testament to the impact that our cloud solutions have on Commercial Operations processes. We look forward to delivering on the vision, improving field force effectiveness and incentivizing the right behaviors across the globe.”

To learn more about Axtria and their cloud solutions, please visit


Contact Information

Tejas Arur, Senior Director - Sales & Marketing



About Boehringer Ingelheim
Boehringer Ingelheim is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, Boehringer Ingelheim operates globally through 145 affiliates and a total of some 47,500 employees. The focus of the family-owned company, founded in 1885, is on researching, developing, manufacturing and marketing new medications of high therapeutic value for human and veterinary medicine.

About Axtria
Axtria helps customers improve operational effectiveness with solutions that leverage Big Data, cloud software, predictive analytics, and machine learning. Axtria has a strong focus on sales and marketing operations in the life science industry. The company works with global customers in over 30 countries.

Axtria SalesIQTM, Axtria MarketingIQTM, and Axtria DataMAxTM are cloud based software platforms that enable customers to manage data, leverage data science to deliver insights for sales and marketing planning, and manage end-to-end commercial operations.


Axtria, Axtria SalesIQ, and Axtria MarketingIQ are registered trademarks of Axtria. Other names may be trademarks of their respective owners.